Franklin Genomic Advancements ETF (HELX) Price, Holdings, & News $27.86 -0.29 (-1.03%) (As of 12/5/2023 ET) Add Compare Share Share Today's Range$27.86▼$27.8650-Day Range$25.36▼$28.4852-Week Range N/AVolume347 shsAverage VolumeN/AMarket Capitalization$9.75 millionAssets Under Management$11.26 millionDividend YieldN/ANet Expense Ratio0.50% Stock AnalysisStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings About Franklin Genomic Advancements ETFThe Franklin Genomic Advancements ETF (HELX) is an exchange-traded fund that is based on the Solactive Genomics index. The fund is an actively managed portfolio of global equity securities of companies relevant to genomic discovery. HELX was launched on Feb 25, 2020 and is managed by Franklin Templeton.Read More HELX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HELX ETF News HeadlinesNovember 25, 2023 | lse.co.ukFranklin Msci China Paris Alig Ucits Etf Share Price (FRCP.MI)November 17, 2023 | lse.co.ukFranklin Emerging Markets Ucits Etf Share Price (FLXE.MI)December 5, 2023 | Autonomix (Ad)How to Invest Early In the Next Potential Breakthrough Nerve-Sensing TechnologyAutonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comFebruary 25, 2023 | morningstar.comBMO ARK Genomic Revolution ETF SeriesSee More Headlines Receive HELX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Franklin Genomic Advancements ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerFranklin Templeton Investments Fund NameFranklin Genomic Advancements ETF Tax ClassificationRegulated Investment Company Stock ExchangeBATSCurrent SymbolBATS:HELX Inception Date2/25/2020 Fund ManagerMatthew J.Moberg, Joyce Lin WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings60 Fund Statistics Assets Under Management$11.26 million Average Daily Volume$0.00 Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorFranklin Templeton Services, LLC AdvisorFranklin Advisers, Inc. CustodianState Street Bank and Trust Company DistributorFranklin Templeton Distributors, Inc. Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerCitadel Miscellaneous Outstanding Shares350,000Beta1.02 Creation Unit50,000 Creation Fee$200.00 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Franklin Genomic Advancements ETF ExpensesTypeHELXTheme ETFsEquity ETFsBATS ETFsAll ETFsManagement Fee0.50%0.57%0.53%0.55%0.50%Other Expenses0.00%0.76%0.53%0.51%0.57%Total Expense0.50%0.73%0.69%0.68%0.69%Fee Waiver0.00%-0.78%-0.54%-0.36%-0.58%Net Expense0.50%0.60%0.59%0.62%0.57% Franklin Genomic Advancements ETF (HELX) Holdings & ExposureTop 10 HELX HoldingsThermo Fisher Scientific(NYSE:TMO)Holding Weight: 6.27%Danaher(NYSE:DHR)Holding Weight: 5.81%Repligen(NASDAQ:RGEN)Holding Weight: 5.65%Medpace(NASDAQ:MEDP)Holding Weight: 5.61%Vertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 3.87%Sartorius AG Participating PreferredHolding Weight: 3.83%Regeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 3.61%Samsung BioLogics Co LtdHolding Weight: 3.23%Krystal Biotech(NASDAQ:KRYS)Holding Weight: 2.68%Corteva(NYSE:CTVA)Holding Weight: 2.67%HELX Sector ExposureHELX Industry ExposureFull Holdings Details Similar ETFsHarbor Corporate Culture Leaders ETFNYSEARCA:HAPYFirst Trust Expanded Technology ETFNYSEARCA:XPNDSpear Alpha ETFNASDAQ:SPRXWisdomTree International ESG FundBATS:RESDJPMorgan Active China ETFNYSEARCA:JCHIInstitutional OwnershipLPL Financial LLCBought 795 shares on 11/13/2023Ownership: 2.607%View All Institutional Transactions HELX ETF - Frequently Asked Questions How have HELX shares performed in 2023? Franklin Genomic Advancements ETF's stock was trading at $30.1272 at the start of the year. Since then, HELX shares have decreased by 7.5% and is now trading at $27.86. View the best growth stocks for 2023 here. What does HELX invest in? Franklin Genomic Advancements ETF is a equity fund issued by Franklin Templeton Investments. HELX focuses on theme investments. The fund's investments total to approximately $11.26 million assets under management. What stocks does Franklin Genomic Advancements ETF hold? HELX invests in 60 holdings. Some of the stocks in their portfolio include Thermo Fisher Scientific (TMO), Danaher (DHR), Repligen (RGEN), Medpace (MEDP), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Krystal Biotech (KRYS), Corteva (CTVA), AstraZeneca (AZN) and Bruker (BRKR). What is the management fee for Franklin Genomic Advancements ETF? Franklin Genomic Advancements ETF's management fee is 0.50% and has no other recorded expenses or fee waivers. The net expense ratio for HELX is 0.50%. Who are Franklin Genomic Advancements ETF's major shareholders? Franklin Genomic Advancements ETF's stock is owned by many different institutional and retail investors. Top institutional shareholders include LPL Financial LLC (2.61%). How do I buy shares of Franklin Genomic Advancements ETF? Shares of HELX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (BATS:HELX) was last updated on 12/5/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Franklin Genomic Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.